LivaNova (LIVN) Non-Current Assets (2015 - 2026)
LivaNova recorded quarterly Non-Current Assets of $1.5 billion in Q1 2026, little changed quarter-over-quarter from $1.5 billion in Q4 2025, and up 8.25% year-over-year from $1.4 billion in Q1 2025.
LivaNova's Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.5 billion for Q1 2026.
- In Q1 2026, Non-Current Assets rose 8.25% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $5.9 billion (up 47.54% YoY), while the FY2025 annual figure was $1.5 billion, up 9.08% from the prior year.
- Non-Current Assets came in at $1.5 billion for Q1 2026 at LivaNova, roughly flat from $1.5 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q1 2022 to a low of -$191.6 million in Q2 2024.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets tumbled 113.69% in 2024 and surged 851.89% in 2025, its largest moves.
- LivaNova's Non-Current Assets stood at $1.4 billion in 2022, then grew by 2.33% to $1.4 billion in 2023, then retreated by 4.32% to $1.4 billion in 2024, then climbed by 9.08% to $1.5 billion in 2025, then decreased by 0.15% to $1.5 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.5 billion, $1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.34 Bn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | -191.59 Mn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.56 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.56 Bn |
| Jun 30, 2021 | 1.59 Bn |
| Mar 31, 2021 | 1.68 Bn |
| Dec 31, 2020 | 1.69 Bn |
| Sep 30, 2020 | 1.85 Bn |
| Jun 30, 2020 | 1.83 Bn |
| Mar 31, 2020 | 1.84 Bn |
| Dec 31, 2019 | 1.86 Bn |
| Sep 30, 2019 | 1.96 Bn |
| Jun 30, 2019 | 2.05 Bn |
| Mar 31, 2019 | 2.06 Bn |
| Dec 31, 2018 | 2.02 Bn |
| Sep 30, 2018 | 2.04 Bn |
| Jun 30, 2018 | 2.04 Bn |
| Mar 31, 2018 | 1.86 Bn |
| Dec 31, 2017 | 1.63 Bn |
| Sep 30, 2017 | 1.88 Bn |
| Jun 30, 2017 | 1.86 Bn |
| Mar 31, 2017 | 1.71 Bn |
| Dec 31, 2016 | 1.53 Bn |
| Sep 30, 2016 | 1.85 Bn |
| Jun 30, 2016 | 1.86 Bn |
| Mar 31, 2016 | 1.93 Bn |
| Dec 31, 2015 | 1.89 Bn |
| Oct 18, 2015 | 75.24 Mn |
| Apr 24, 2015 | 75.22 Mn |